Pharma pricing is in the media and political spotlight. While the spotlight may fade eventually, it is critical for biopharmaceutical executives to understand the stakeholder dynamics that make these concerns real and enduring. All stakeholders – providers, employers/payers and especially consumers – understand the real value of treatments and cures, yet face equally real cost pressure. So how can biopharmaceutical companies succeed?
Hear from Jennifer Colamonico and consultant Kim Slocum as they discuss the most important market trends that you need to know for smarter strategic business planning. Learn about the red flags to monitor, understand the mindset of other stakeholders around the table and examine the key decisions you can make to enrich your value proposition to payers.